SUBSCRIBE
SUBSCRIBE
Pharm Country

Merck & Co., Inc. Release: Isentress™ (Raltegravir) Awarded Prix Galien USA Top Honor

September 25, 2008 | 
1 min read

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ISENTRESS™ (raltegravir), Merck’s medicine for HIV/AIDS, received the Prix Galien USA 2008 Award for Best Pharmaceutical Agent, Merck & Co., Inc. announced today.

MORE ON THIS TOPIC
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: Mother covering her face, experiencing depression symptoms
Drug Development
Novo-Backed Reunion Raises $103M Series A Financing for Psychedelic Trial
May 3, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto
Business
BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases
April 29, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Injection pens meant for weight-loss medications
Business
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market
April 18, 2024
 · 
2 min read
 · 
Tyler Patchen